Skip to content
Sign in
StableMarketsBusinessFinanceReported 2026-11-14 11:13

Windward Bio completes Nasdaq IPO

Windward Bio, a clinical‑stage biotech, listed on Nasdaq on November 13, 2026, pricing its shares at $17.00 and closing at $28.50 on the first day, creating a market cap of about $1.69 billion.

Why it matters. The IPO provides Windward Bio with capital and public market visibility, affecting its ability to fund research and development and influencing investors in the biotech sector.

01

Evidence

  • PPR Newswire news releasesCompany2026-11-14 11:13
    Windward Bio (Nasdaq: WWB) priced its IPO at $17.00 per share.
    View source
  • GGDELT Global Knowledge GraphMedia2026-11-14 15:15
    View source
  • GGDELT Global Knowledge GraphMedia2026-11-14 16:15
    View source
  • GGDELT Global Knowledge GraphMedia2026-11-15 00:15
    View source
  • GGDELT Global Knowledge GraphMedia2026-11-15 00:45
    View source